Stay updated on Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows a consolidated Locations section for California, Michigan, and Missouri, replacing the separate California Locations, Michigan Locations, and Missouri Locations subsections; the revision is updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.4%
    Check dated 2025-12-23T20:29:30.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Two minor textual edits clarify PubMed-generated publications and update the page revision from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:43:08.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The government funding/operating-status notice for the NIH Clinical Center was removed from the page, a minor housekeeping change that does not affect study details or user-facing functionality.
    Difference
    0.3%
    Check dated 2025-11-18T06:56:45.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Observed a minor administrative update (new last update date) with no substantive changes to study design, primary/secondary outcomes, eligibility criteria, or participating locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:03:48.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T05:23:15.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Page updates version from v3.0.2 to v3.1.0 and removes a specific disease resource; otherwise, core content remains unchanged.
    Difference
    0.4%
    Check dated 2025-09-29T03:01:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.